Pharmaron Beijing Co., Ltd.
Status: Publicly traded
Direct answer
Pharmaron Beijing Co., Ltd. is publicly traded on HKSE under the ticker 3759.HK.
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and...
Can you invest in Pharmaron Beijing Co., Ltd.?
Yes. Pharmaron Beijing Co., Ltd. is publicly traded on HKSE under the ticker 3759.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Pharmaron Beijing Co., Ltd.
Detailed equity research is provided by MarketSnap.